DB Stock Overview
An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Decibel Cannabis Company Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.065 |
| 52 Week High | CA$0.15 |
| 52 Week Low | CA$0.035 |
| Beta | 1.03 |
| 11 Month Change | 30.00% |
| 3 Month Change | -13.33% |
| 1 Year Change | -55.17% |
| 33 Year Change | -63.89% |
| 5 Year Change | n/a |
| Change since IPO | -63.89% |
Recent News & Updates
Recent updates
Investors Don't See Light At End Of Decibel Cannabis Company Inc.'s (CVE:DB) Tunnel And Push Stock Down 29%
Oct 13
Decibel Cannabis Company Inc. (CVE:DB) Stock's 33% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Aug 15Decibel Cannabis (CVE:DB) Takes On Some Risk With Its Use Of Debt
Jul 27Decibel Cannabis Company Inc. (CVE:DB) Analysts Are Cutting Their Estimates: Here's What You Need To Know
Jun 02Sentiment Still Eluding Decibel Cannabis Company Inc. (CVE:DB)
Mar 06Here's Why Decibel Cannabis (CVE:DB) Is Weighed Down By Its Debt Load
Jan 10We Think Decibel Cannabis (CVE:DB) Is Taking Some Risk With Its Debt
Sep 28Cautious Investors Not Rewarding Decibel Cannabis Company Inc.'s (CVE:DB) Performance Completely
Jul 15Is Decibel Cannabis (CVE:DB) Using Debt Sensibly?
May 17Decibel Cannabis (CVE:DB) Has Debt But No Earnings; Should You Worry?
Nov 11Decibel Cannabis (CVE:DB) Use Of Debt Could Be Considered Risky
Jul 22Does Decibel Cannabis (CVE:DB) Have A Healthy Balance Sheet?
Nov 24Here's Why Decibel Cannabis (CVE:DB) Has A Meaningful Debt Burden
Aug 21Would Decibel Cannabis (CVE:DB) Be Better Off With Less Debt?
Apr 16Is Decibel Cannabis (CVE:DB) A Risky Investment?
Dec 28
Shareholder Returns
| DB | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | -13.3% | -6.1% | 0.7% |
| 1Y | -55.2% | -22.3% | 21.7% |
Return vs Industry: DB underperformed the Canadian Pharmaceuticals industry which returned -22.8% over the past year.
Return vs Market: DB underperformed the Canadian Market which returned 21.4% over the past year.
Price Volatility
| DB volatility | |
|---|---|
| DB Average Weekly Movement | 15.7% |
| Pharmaceuticals Industry Average Movement | 11.5% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CA Market | 17.6% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: DB's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: DB's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of Canadian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Benjamin Sze | www.decibelcc.com |
Decibel Cannabis Company Inc., an integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada. It is also involved in the extraction, processing, and manufacturing vape cartridges, cannabis infused products, cannabis extracts, and glass tube packaging for pre-rolls. In addition, the company engages in the cannabis retail business through operating operational retail locations in Saskatchewan, as well as an e-commerce cannabis platform throughout the Province of Saskatchewan; and operational retail locations in Alberta.
Decibel Cannabis Company Inc. Fundamentals Summary
| DB fundamental statistics | |
|---|---|
| Market cap | CA$28.77m |
| Earnings (TTM) | -CA$472.00k |
| Revenue (TTM) | CA$105.60m |
0.3x
P/S Ratio-60.9x
P/E RatioIs DB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DB income statement (TTM) | |
|---|---|
| Revenue | CA$105.60m |
| Cost of Revenue | CA$61.12m |
| Gross Profit | CA$44.48m |
| Other Expenses | CA$44.95m |
| Earnings | -CA$472.00k |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 21, 2024
| Earnings per share (EPS) | -0.0011 |
| Gross Margin | 42.12% |
| Net Profit Margin | -0.45% |
| Debt/Equity Ratio | 92.0% |
How did DB perform over the long term?
See historical performance and comparison